Unihealth Hospitals Limited engaged with analysts and institutional investors on June 22, 2026, to discuss its business operations. The meeting, conducted virtually via Zoom from 12:00 P.M. to 1:00 P.M., served as a platform for the company's officials to present updates and answer queries from the investment community. No unpublished price sensitive information (UPSI) was shared during the session.

The disclosure was made to the National Stock Exchange of India Ltd. in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Deshna Jain, Company Secretary & Compliance Officer, signed the intimation confirming the participation and the adherence to regulatory norms regarding information disclosure.

A total of 19 participants attended the meeting, representing various financial institutions and high-net-worth individuals. The attendees included Profit Tantra Financials Services Ltd., Podar Family Office, Pin Point X Capital, and Samdeerya Capital. Other institutional participants such as Mindtree Capital, Wealth & Wisdom, Coheron Wealth, and Wallfort PMS were also present.

The list of attendees further included Lotus bloom and Alpha AIF, alongside multiple High Net-Worth Individuals (HNIs). The interaction provided these stakeholders with an opportunity to understand the company's current standing and future outlook without the disclosure of material non-public information.

Attendee Details

unihealth hospitals announced the successful completion of its first Intravascular Ultrasound (IVUS)-guided coronary intervention at UMC Hospitals in Navi Mumbai on June 17, 2026. This milestone marks a significant advancement in the hospital's cardiac care capabilities, enhancing the precision of treatments for coronary artery disease. The procedure was performed by Dr. Shrikant Naigude, utilizing advanced imaging technology to visualize artery walls and optimize stent deployment.

The adoption of IVUS technology offers several clinical advantages, including enhanced procedural accuracy and improved long-term outcomes. By providing detailed cross-sectional images of the vessel wall, the technology allows cardiologists to accurately assess blockages and ensure precise stent expansion. This reduces the risk of complications such as stent thrombosis and lowers the likelihood of restenosis, or the re-narrowing of arteries.

Financial Performance for FY26

Unihealth Hospitals Limited reported strong financial results for the fiscal year ended March 31, 2026. The company achieved growth across key operational metrics, reflecting its focus on expanding healthcare infrastructure and services.

Strategic Expansion and Clinical Excellence

The successful execution of the IVUS-guided procedure aligns with the company's strategy to invest in advanced medical technologies and evidence-based treatment protocols. Dr. Akshay Parmar, Founder and Managing Director of Unihealth Hospitals Limited, stated that the introduction of this technology reflects the company's commitment to bringing globally accepted healthcare solutions to the communities it serves.

UMC Hospitals offers a broad spectrum of medical and surgical specialties, including cardiology, critical care, and orthopaedics. The facility is supported by modern catheterization laboratory infrastructure and multidisciplinary teams dedicated to comprehensive cardiovascular care. This initiative is part of a broader effort to strengthen the company's position as a centre for quality healthcare delivery in the Mumbai Metropolitan Region.